Biosimilar agalsidase beta

agalsidase beta · Bio Sidus SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Biosimilar agalsidase beta, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease [Phase 3]